---
schema_version: "secwatch.filing_event.v1"
accession: "0001021771-24-000166"
form_type: "8-K"
ticker: "BRTX"
cik: "0001505497"
company_name: "BioRestorative Therapies, Inc."
filed_at: "2024-08-13T23:59:59+00:00"
generated_at: "2026-05-31T09:41:07.220231+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# BioRestorative Therapies issues Q2 2024 results press release; specific figures not provided

## Summary
- Press release announcing Q2 2024 financial results was issued on August 13, 2024.
- Press release includes a business update and details for a conference call to discuss results.
- No specific financial data (revenue, EPS, etc.) are available from the filing text provided.
- The filing serves as a notice that results were released, but exhibit content is missing.

## SEC filing metadata
- accession: 0001021771-24-000166
- form_type: 8-K
- ticker: BRTX
- cik: 0001505497
- company_name: BioRestorative Therapies, Inc.
- filed_at: 2024-08-13T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000166/0001021771-24-000166-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1505497/000102177124000166/brt81324.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001021771-24-000166
- JSON: https://secwatch.observer/filing/0001021771-24-000166.json
- Plain text: https://secwatch.observer/filing/0001021771-24-000166.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.